Form 8-K · Current Report · Filed 2024-12-13
West Pharmaceutical Services Authorizes Share Repurchase Program
On December 9, 2024, West Pharmaceutical Services, Inc.'s Board of Directors approved a share repurchase program to repurchase up to 550,000 shares of the company's common stock by December 31, 2025.
- Filer
- West Pharmaceutical Services Inc. WST · NYSE
- Filed
- Accession
- 0000105770-24-000088
- CIK
- 0000105770
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
This program follows the expiration of the company's previous repurchase program by December 31, 2024.
Items reported
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$331.62
Next session
-0.3%
Since filing
+2.8%
Latest close
$340.96
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from WST reporting the same item, with the next session's move:
About West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.
Never miss another WST filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.